Sign in

CIK 0001699350 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

SHOULDER INNOVATIONS, INC.

Sign in to watch
Ticker
SI
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
270538764
Phone
616-294-1026
Business address
1535 STEELE AVENUE SW, SUITE B, GRAND RAPIDS, MI, 49507
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,246,952
in 4 filings, $465K under 10b5-1 plans

Net −$1,246,952. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gilde Healthcare Holding B.V. −$594K 10% owner sold 1% of stake
  2. Ahearn Matthew Fraser −$465K Chief Operating Officer sold 8% of stake
  3. Ball Robert Joseph −$188K CEO & Executive Chairman sold 3% of stake
Date Insider Transaction Shares Price Value Owned after
2025-08-01 Ahearn Matthew Fraser CHIEF OPERATING OFFICER Conversion · Series B Convertible Preferred Stock −218,217 0
2025-08-01 LSV Associates II, LLC Former 10% Owner Conversion +1,618,470 1,618,470
2025-08-01 LSV Associates II, LLC Former 10% Owner Purchase +266,666 $15.00 $4.0M 1,885,136
2025-08-01 LSV Associates II, LLC Former 10% Owner Conversion · Series C Convertible Preferred Stock −20,930,233 0
2025-08-01 LSV Associates II, LLC Former 10% Owner Conversion · Series D Convertible Preferred Stock −9,950,208 0
2025-08-01 Carusi Michael A Director Conversion +1,618,470 1,618,470
2025-08-01 Carusi Michael A Director Purchase +266,666 $15.00 $4.0M 1,885,136
2025-08-01 Carusi Michael A Director Grant or award +7,666 7,666
2025-08-01 Carusi Michael A Director Conversion · Series C Convertible Preferred Stock −20,930,233 0
2025-08-01 Carusi Michael A Director Conversion · Series D Convertible Preferred Stock −9,950,208 0
2025-08-01 BUCKMAN PAUL Director Conversion +6,198 6,198
2025-08-01 BUCKMAN PAUL Director Grant or award +7,666 13,864
2025-08-01 BUCKMAN PAUL Director Conversion · Series D Convertible Preferred Stock −118,268 0
2025-08-01 Buchholz Richard Director Grant or award +7,666 7,666
2025-08-01 Buchholz Richard Director Purchase +5,000 $15.00 $75K 12,666
2025-08-01 Blue David Lawrence SEE REMARKS Conversion +43,937 43,937
2025-08-01 Blue David Lawrence SEE REMARKS Conversion · Series Seed Convertible Preferred Stock −100,000 0
2025-08-01 Blue David Lawrence SEE REMARKS Conversion · Series A Convertible Preferred Stock −346,333 0
2025-08-01 Blue David Lawrence SEE REMARKS Conversion · Series B Convertible Preferred Stock −308,916 0
2025-08-01 Blue David Lawrence SEE REMARKS Conversion · Series C Convertible Preferred Stock −46,512 0

Page 6 of 7 · 132 trades